Pulien Pharma's Lacosamide Injection Receives Marketing Authorization in Italy

People’s Financial News, March 16 — Hainan Puli Pharmaceutical Co., Ltd. recently received approval from the Italian Medicines Agency (Agenzia Italiana del Farmaco, “AIFA”) for the marketing of Lacosamide Injection. This marks that Puli Pharmaceutical’s Lacosamide Injection is qualified for sale and distribution in Italy.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments